Summary
Profile
| Metric | Value |
|---|---|
| Name | Tema Neuroscience And Mental Health ETF |
| Assets Under Management | $10.28M |
| Expense Ratio | 0.75% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 23.37K USD |
| Website | temaetfs.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| VRTX | 10.33% | |
| REGN | 8.09% | |
| ALNY | 7.74% | |
| ARGX | 5.83% | |
| NBIX | 4.89% | |
| TEVA | 4.32% | |
| LLY | 4.06% | |
| CRNX | 3.54% | |
| IONS | 3.48% | |
| SYK | 3.22% | |
| BIIB | 3.21% | |
| MDT | 2.58% | |
| UCB.BR | 2.48% | |
| ACAD | 2.42% | |
| CPRX | 2.33% | |
| AXSM | 2.33% | |
| 2.08% | ||
| DNLI | 1.98% | |
| RNA | 1.88% | |
| JAZZ | 1.88% | |
| XENE | 1.81% | |
| DXCM | 1.72% | |
| SRRK | 1.71% | |
| PTCT | 1.58% | |
| ALKS | 1.53% | |
| PEN | 1.46% | |
| DAWN | 1.44% | |
| OPCH | 1.37% | |
| SHL.DE | 1.30% | |
| ORNBV.HE | 1.14% |
Chart
SUGGESTED SERIES
Technicals
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| $0.26 | ||
| Upcoming | N/A | N/A |
| - | ||
| - |
Country Weights
| Country | Weight |
|---|---|
| United States | 74.62% |
| Ireland | 6.42% |
| Netherlands | 5.83% |
| Israel | 4.32% |
| Belgium | 2.48% |
| Canada | 1.81% |
| Germany | 1.30% |
| Finland | 1.14% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 92.99% |
FAQ
- Does MNTL pay dividends?
- Yes, the Tema Neuroscience And Mental Health ETF does pays dividends, with the most recent payment being $0.26 per share. The last ex-dividend date was on December 11, 2024, and the next ex-dividend date has not been announced yet
- What stocks are in MNTL?
- As of today, Tema Neuroscience And Mental Health ETF includes 42 holdings, with 38 of them being companies from 8 different countries and 1 sectors. The most weighted holdings are Vertex Pharmaceuticals Incorporated (10.33%), Regeneron Pharmaceuticals, Inc. (8.09%) and Alnylam Pharmaceuticals, Inc. (7.74%)
- What is the current assets under management for MNTL?
- Assets under management of Tema Neuroscience And Mental Health ETF is $10M
- What is MNTL average volume?
- Average volume of Tema Neuroscience And Mental Health ETF is $360
- What is MNTL expense ratio?
- Expense ratio of Tema Neuroscience And Mental Health ETF is 0.75%
- What is MNTL inception date?
- Inception date of Tema Neuroscience And Mental Health ETF is January 22, 2024
Data Sources & References
- MNTL Official Website temaetfs.com/mntl
- MNTL Profile on Yahoo Finance finance.yahoo.com/quote/MNTL